Anti‐tumorigenic effects of naive and TLR4‐primed adipose‐derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells

Background One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Theref...

Full description

Saved in:
Bibliographic Details
Published inCancer medicine (Malden, MA) Vol. 13; no. 2; pp. e6964 - n/a
Main Authors Kaçaroğlu, Demet, Yaylacı, Seher, Gurbuz, Nilgun
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.01.2024
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN2045-7634
2045-7634
DOI10.1002/cam4.6964

Cover

Loading…
Abstract Background One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4‐activated, and TLR4‐inhibited phenotypes of adipose‐derived MSCs (ADMSC) on pancreatic ductal cell line (Panc‐1). Methods and Materials Adipose‐derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti‐inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc‐1 cells was inhibited when naive ADMSCs:Panc‐1(10:1) and proinflammatory ADMSCs:Panc‐1(10:1) were directly cocultured. Results In indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10‐fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc‐1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc‐1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc‐1 cells. However, it was observed that anti‐inflammatory ADMSCs showed tumor‐promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc‐1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment. Conclusions These findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy. In our study, we showed that the tumorigenic effects of ADMSCs on Panc‐1 cells were altered when stimulated via TLR4 signaling, but this effect was altered when naive ADMSCs and ADMSCs with pro‐inflammatory character stimulated by TLR4 agonist exerted anticarcinogenic effects on Panc‐1 cells. Anti‐inflammatory ADMSCs, on the other hand, showed tumor‐promoting effects. Understanding the role of MSCs in the tumor microenvironment will be a guiding factor for the development of microenvironment‐targeted therapeutic approaches in the future.
AbstractList One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4-activated, and TLR4-inhibited phenotypes of adipose-derived MSCs (ADMSC) on pancreatic ductal cell line (Panc-1).BACKGROUNDOne of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4-activated, and TLR4-inhibited phenotypes of adipose-derived MSCs (ADMSC) on pancreatic ductal cell line (Panc-1).Adipose-derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti-inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc-1 cells was inhibited when naive ADMSCs:Panc-1(10:1) and proinflammatory ADMSCs:Panc-1(10:1) were directly cocultured.METHODS AND MATERIALSAdipose-derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti-inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc-1 cells was inhibited when naive ADMSCs:Panc-1(10:1) and proinflammatory ADMSCs:Panc-1(10:1) were directly cocultured.In indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10-fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc-1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc-1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc-1 cells. However, it was observed that anti-inflammatory ADMSCs showed tumor-promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc-1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment.RESULTSIn indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10-fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc-1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc-1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc-1 cells. However, it was observed that anti-inflammatory ADMSCs showed tumor-promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc-1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment.These findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy.CONCLUSIONSThese findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy.
Background One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4‐activated, and TLR4‐inhibited phenotypes of adipose‐derived MSCs (ADMSC) on pancreatic ductal cell line (Panc‐1). Methods and Materials Adipose‐derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti‐inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc‐1 cells was inhibited when naive ADMSCs:Panc‐1(10:1) and proinflammatory ADMSCs:Panc‐1(10:1) were directly cocultured. Results In indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10‐fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc‐1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc‐1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc‐1 cells. However, it was observed that anti‐inflammatory ADMSCs showed tumor‐promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc‐1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment. Conclusions These findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy. In our study, we showed that the tumorigenic effects of ADMSCs on Panc‐1 cells were altered when stimulated via TLR4 signaling, but this effect was altered when naive ADMSCs and ADMSCs with pro‐inflammatory character stimulated by TLR4 agonist exerted anticarcinogenic effects on Panc‐1 cells. Anti‐inflammatory ADMSCs, on the other hand, showed tumor‐promoting effects. Understanding the role of MSCs in the tumor microenvironment will be a guiding factor for the development of microenvironment‐targeted therapeutic approaches in the future.
BackgroundOne of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4-activated, and TLR4-inhibited phenotypes of adipose-derived MSCs (ADMSC) on pancreatic ductal cell line (Panc-1).Methods and MaterialsAdipose-derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti-inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc-1 cells was inhibited when naive ADMSCs:Panc-1(10:1) and proinflammatory ADMSCs:Panc-1(10:1) were directly cocultured.ResultsIn indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10-fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc-1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc-1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc-1 cells. However, it was observed that anti-inflammatory ADMSCs showed tumor-promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc-1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment.ConclusionsThese findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy.
One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the effects of mesenchymal stem cells (MSCs) and their inflammatory phenotypes on cancer cells have been a subject of controversy. Therefore, it is crucial to elucidate the underlying mechanisms of this interaction, especially in the context of pancreatic cancer. We aimed to investigate the effects of naive, TLR4-activated, and TLR4-inhibited phenotypes of adipose-derived MSCs (ADMSC) on pancreatic ductal cell line (Panc-1). Adipose-derived MSCs were induced into a proinflammatory phenotype using a 0.5 μg/mL dose of TLR4 agonist, while an anti-inflammatory phenotype was generated in ADMSCs using a 25 μg/mL dose of TLR4 antagonist. We observed that the proliferation of Panc-1 cells was inhibited when naive ADMSCs:Panc-1(10:1) and proinflammatory ADMSCs:Panc-1(10:1) were directly cocultured. In indirect coculture, both naive and proinflammatory ADMSCs exhibited a significant 10-fold increase in their inhibitory effect on the proliferation and colony forming capacity of Panc-1 cells, with the added benefit of inducing apoptosis. In our study, both naive and proinflammatory ADMSCs were found to regulate the expression of genes associated with metastasis (MMP2, KDR, MMP9, TIMP1, IGF2R, and COL1A1) and EMT (CDH1, VIM, ZEB1, and CLDN1) in Panc-1 cells. Remarkably, both naive and proinflammatory ADMSCs demonstrated antitumor effects on Panc-1 cells. However, it was observed that anti-inflammatory ADMSCs showed tumor-promoting effects instead. Furthermore, we observed a reciprocal influence between ADMSCs and Panc-1 cells on each other's proinflammatory cytokine expressions, suggesting a dynamic interplay within the tumor microenvironment. These findings underscore the significance of both the naive state and different inflammatory phenotypes of MSCs in the microenvironment and represent a pivotal step toward the development of novel therapeutic approaches for pancreatic cancer. Understanding the intricate interactions between MSCs and cancer cells may open new avenues for targeted interventions in cancer therapy.
In our study, we showed that the tumorigenic effects of ADMSCs on Panc‐1 cells were altered when stimulated via TLR4 signaling, but this effect was altered when naive ADMSCs and ADMSCs with pro‐inflammatory character stimulated by TLR4 agonist exerted anticarcinogenic effects on Panc‐1 cells. Anti‐inflammatory ADMSCs, on the other hand, showed tumor‐promoting effects. Understanding the role of MSCs in the tumor microenvironment will be a guiding factor for the development of microenvironment‐targeted therapeutic approaches in the future.
Author Kaçaroğlu, Demet
Yaylacı, Seher
Gurbuz, Nilgun
AuthorAffiliation 1 Department of Medical Biology, Faculty of Medicine Suleyman Demirel University Isparta Turkey
2 Department of Medical Biology, Faculty of Medicine Lokman Hekim University Ankara Turkey
AuthorAffiliation_xml – name: 2 Department of Medical Biology, Faculty of Medicine Lokman Hekim University Ankara Turkey
– name: 1 Department of Medical Biology, Faculty of Medicine Suleyman Demirel University Isparta Turkey
Author_xml – sequence: 1
  givenname: Demet
  orcidid: 0000-0003-4920-0516
  surname: Kaçaroğlu
  fullname: Kaçaroğlu, Demet
  email: demetkacaroglu@gmail.com
  organization: Lokman Hekim University
– sequence: 2
  givenname: Seher
  orcidid: 0000-0003-3309-2303
  surname: Yaylacı
  fullname: Yaylacı, Seher
  email: seher.yaylaci@lokmanhekim.edu.tr
  organization: Lokman Hekim University
– sequence: 3
  givenname: Nilgun
  orcidid: 0000-0003-4476-5593
  surname: Gurbuz
  fullname: Gurbuz, Nilgun
  email: nilgungurbuz@sdu.edu.tr
  organization: Suleyman Demirel University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38379331$$D View this record in MEDLINE/PubMed
BookMark eNp1ks1u1DAUhS1UREvpghdAltjAYlonju14hUYj_qRBSKisLde-aV0l9mAnRbNjyZJn5Em4YaaoVOCNLd_vHp1j38fkIKYIhDyt2GnFWH3m7NCcSi2bB-SoZo1YKMmbgzvnQ3JSyjXDpVgtVfWIHPKWK815dUS-L-MYfn77MU5DyuESYnAUug7cWGjqaLThBqiNnp6vPzXIbXIYwFPrwyYVwAsPGRFPBygQ3dV2sD0tIwzUQd-jRqQbG10GO6Kyn9yIdeshJmezCzENdkc-IQ872xc42e_H5POb1-erd4v1x7fvV8v1wjW4FrzTredMaJDAQHvR1M4pD1azynZCacmZVCBar2rJuwshuGwc5rXCMvAtPyavdrqb6QKTOIhjtr2Zc9m8NckG83clhitzmW5MxVpe6Yqjwou9Qk5fJiijGUKZM9gIaSqm1rUWHI1IRJ_fQ6_TlCPmm6lWcSlYjdSzu5b-eLn9JQTOdoDLqZQMnXFhxAdNs8PQozUzj4KZR8HMo4AdL-913Ir-i92rfw09bP8PmtXyQ_O74xe92cdG
CitedBy_id crossref_primary_10_3390_ijms25158352
crossref_primary_10_1016_j_heliyon_2024_e29858
crossref_primary_10_1016_j_biopha_2024_117745
Cites_doi 10.3748/wjg.v17.i24.2897
10.1002/IJC.31775
10.1158/0008-5472.CAN-14-0155
10.3389/FCELL.2020.00447
10.1002/JCB.25284
10.1016/j.ymeth.2008.03.006
10.3390/ijms20153827
10.1038/s41419-019-1959-5
10.1371/JOURNAL.PONE.0010088
10.1016/S0140-6736(20)30974-0
10.1016/j.tice.2020.101479
10.1371/journal.pone.0045590
10.1186/s12943-018-0858-1
10.1038/s41598-023-34915-0
10.18295/squmj.2018.18.03.002
10.15171/apb.2019.024
10.1186/S13287-022-02910-3/FIGURES/7
10.3389/fonc.2022.1047907
10.1038/nrdp.2016.22
10.1016/J.JSS.2007.12.757
10.1016/J.CIS.2019.03.002
10.1186/1756-8722-7-14
10.1155/2015/361326
10.1186/s40364-020-00228-x
10.1371/journal.pone.0006278
10.1016/j.bbcan.2013.10.004
10.1016/J.SEMCANCER.2015.02.006
10.1155/2017/4015039
10.1016/J.NEO.2016.01.005
10.2174/138920371604150429152720
10.1016/j.semcancer.2017.03.008
10.1371/journal.pone.0149876
10.5772/31933
ContentType Journal Article
Copyright 2024 The Authors. published by John Wiley & Sons Ltd.
2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 The Authors. published by John Wiley & Sons Ltd.
– notice: 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
– notice: 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
7X8
5PM
DOI 10.1002/cam4.6964
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Publicly Available Content Database
MEDLINE

Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Kaçaroğlu et al
EISSN 2045-7634
EndPage n/a
ExternalDocumentID PMC10831913
38379331
10_1002_cam4_6964
CAM46964
Genre researchArticle
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
Germany
California
GeographicLocations_xml – name: United States--US
– name: Germany
– name: California
GrantInformation_xml – fundername: Suleyman Demirel University Scientific Research Projects Coordination Unit
  funderid: TDK‐2022‐8583
– fundername: Suleyman Demirel University Scientific Research Projects Coordination Unit
  grantid: TDK-2022-8583
– fundername: Suleyman Demirel University Scientific Research Projects Coordination Unit
  grantid: TDK‐2022‐8583
GroupedDBID 0R~
1OC
24P
31~
53G
5VS
7X7
8-0
8-1
8FE
8FH
8FI
8FJ
AAHHS
AAZKR
ABDBF
ABUWG
ACCFJ
ACCMX
ACUHS
ACXQS
ADBBV
ADKYN
ADPDF
ADRAZ
ADZMN
ADZOD
AEEZP
AENEX
AEQDE
AFKRA
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
D-8
D-9
DIK
EBS
EJD
FYUFA
GODZA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
HZ~
IAO
IHR
ITC
KQ8
LK8
M48
M7P
M~E
O9-
OK1
OVD
PIMPY
PQQKQ
PROAC
RPM
TEORI
TUS
UKHRP
WIN
AAYXX
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
PQGLB
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c4444-3f98d3059e6e0e9d542cc7dea901af57963067e58d7263fb55364c383a5a0ed83
IEDL.DBID M48
ISSN 2045-7634
IngestDate Thu Aug 21 18:35:33 EDT 2025
Fri Jul 11 12:13:43 EDT 2025
Wed Aug 13 06:17:05 EDT 2025
Mon Jul 21 06:03:21 EDT 2025
Thu Apr 24 22:51:43 EDT 2025
Tue Jul 01 02:16:34 EDT 2025
Wed Jan 22 16:15:26 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords MSC1
pancreatic cancer
tumor microenvironment
TLR4
mesenchymal stem cells
Language English
License Attribution
2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4444-3f98d3059e6e0e9d542cc7dea901af57963067e58d7263fb55364c383a5a0ed83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-4920-0516
0000-0003-4476-5593
0000-0003-3309-2303
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1002/cam4.6964
PMID 38379331
PQID 2928736502
PQPubID 2032540
PageCount 17
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10831913
proquest_miscellaneous_2929539636
proquest_journals_2928736502
pubmed_primary_38379331
crossref_citationtrail_10_1002_cam4_6964
crossref_primary_10_1002_cam4_6964
wiley_primary_10_1002_cam4_6964_CAM46964
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2024
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: January 2024
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bognor Regis
– name: Hoboken
PublicationTitle Cancer medicine (Malden, MA)
PublicationTitleAlternate Cancer Med
PublicationYear 2024
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
References 2015; 35
2021; 68
2019; 9
2013; 1836
2023; 13
2015; 16
2017; 2017
2012
2019; 10
2017; 44
2019; 267
2008; 149
2011; 17
2016; 18
2019; 144
2016; 11
2020; 8
2018; 18
2018; 17
2016; 2
2019; 20
2020; 395
2015; 2015
2022; 12
2022; 13
2008; 45
2016; 117
2009; 4
2014; 74
2020; 0
2012; 7
2014; 7
2010; 5
e_1_2_11_10_1
e_1_2_11_32_1
e_1_2_11_31_1
e_1_2_11_30_1
e_1_2_11_14_1
e_1_2_11_13_1
e_1_2_11_12_1
e_1_2_11_34_1
e_1_2_11_11_1
e_1_2_11_33_1
e_1_2_11_7_1
e_1_2_11_29_1
e_1_2_11_6_1
e_1_2_11_28_1
e_1_2_11_5_1
e_1_2_11_27_1
e_1_2_11_4_1
e_1_2_11_26_1
e_1_2_11_3_1
e_1_2_11_2_1
e_1_2_11_21_1
e_1_2_11_20_1
e_1_2_11_25_1
e_1_2_11_24_1
e_1_2_11_9_1
e_1_2_11_23_1
e_1_2_11_8_1
e_1_2_11_22_1
e_1_2_11_18_1
e_1_2_11_17_1
e_1_2_11_16_1
e_1_2_11_15_1
e_1_2_11_19_1
References_xml – volume: 149
  start-page: 319
  issue: 2
  year: 2008
  end-page: 328
  article-title: The role of the tumor microenvironment in the progression of pancreatic cancer
  publication-title: J Surg Res
– volume: 0
  start-page: 447
  year: 2020
  article-title: The multifaceted roles of MSCs in the tumor microenvironment: interactions with immune cells and exploitation for therapy
  publication-title: Front Cell Dev Biol
– volume: 13
  start-page: 1
  issue: 1
  year: 2022
  end-page: 17
  article-title: Human amniotic fluid mesenchymal stem cells attenuate pancreatic cancer cell proliferation and tumor growth in an orthotopic xenograft mouse model
  publication-title: Stem Cell Research and Therapy
– volume: 7
  start-page: e45590
  issue: 9
  year: 2012
  article-title: Mesenchymal stem cell 1 (MSC1)‐based therapy attenuates tumor growth whereas MSC2‐treatment promotes tumor growth and metastasis
  publication-title: PLoS One
– volume: 8
  start-page: 49
  year: 2020
  article-title: Roles of IFN‐γ in tumor progression and regression: a review
  publication-title: Biomark Res
– volume: 1836
  start-page: 321
  issue: 2
  year: 2013
  end-page: 335
  article-title: Tumor microenvironment: bone marrow‐mesenchymal stem cells as key players
  publication-title: Biochim Biophys Acta Rev Cancer
– volume: 10
  issue: 10
  year: 2019
  article-title: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma
  publication-title: Cell Death Dis
– volume: 16
  start-page: 295
  issue: 4
  year: 2015
  end-page: 300
  article-title: The LPS‐pretreated MSCs supply a positive microenvironment for tumor cell proliferation and clone formation
  publication-title: Curr Protein Pept Sci
– volume: 267
  start-page: 47
  year: 2019
  end-page: 61
  article-title: Engineering nanocellulose hydrogels for biomedical applications
  publication-title: Adv Colloid Interf Sci
– volume: 2015
  year: 2015
  article-title: Lipopolysaccharide from attenuates microglia‐mediated inflammation and phagocytosis and directs regulatory T cell response
  publication-title: Int J Inflamm
– volume: 11
  issue: 3
  year: 2016
  article-title: TLR4 activation promotes bone marrow MSC proliferation and osteogenic differentiation via wnt3a and wnt5a signaling
  publication-title: PLoS One
– volume: 74
  start-page: 2913
  issue: 11
  year: 2014
  end-page: 2921
  article-title: Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States
  publication-title: Cancer Res
– volume: 17
  start-page: 2897
  issue: 24
  year: 2011
  end-page: 2908
  article-title: Molecular biology of pancreatic cancer
  publication-title: World J Gastroenterol
– volume: 12
  year: 2022
  article-title: MSCs can be a double‐edged sword in tumorigenesis
  publication-title: Front Oncol
– volume: 7
  start-page: 1
  issue: 1
  year: 2014
  end-page: 10
  article-title: The roles of mesenchymal stem cells in tumor inflammatory microenvironment
  publication-title: J Hematol Oncol
– volume: 2017
  start-page: 1
  year: 2017
  end-page: 17
  article-title: The immunomodulatory effects of mesenchymal stem cell polarization within the tumor microenvironment niche
  publication-title: Stem Cells Int
– volume: 395
  start-page: 2008
  issue: 10242
  year: 2020
  end-page: 2020
  article-title: Pancreatic cancer
  publication-title: Lancet
– volume: 35
  start-page: S25
  issue: Suppl
  year: 2015
  end-page: S54
  article-title: Sustained proliferation in cancer: mechanisms and novel therapeutic targets
  publication-title: Semin Cancer Biol
– volume: 20
  start-page: 1
  issue: 15
  year: 2019
  end-page: 32
  article-title: Current strategies to enhance adipose stem cell function: an update
  publication-title: Int J Mol Sci
– volume: 5
  issue: 4
  year: 2010
  article-title: A new mesenchymal stem cell (MSC) paradigm: polarization into a pro‐inflammatory MSC1 or an immunosuppressive MSC2 phenotype
  publication-title: PLoS One
– volume: 17
  start-page: 4
  issue: 108
  year: 2018
  end-page: 15
  article-title: Tumor microenvironment participates in metastasis of pancreatic cancer
  publication-title: Mol Cancer
– volume: 44
  start-page: 153
  year: 2017
  end-page: 169
– volume: 18
  start-page: e264
  issue: 3
  year: 2018
  end-page: e277
  article-title: Sources and clinical applications of mesenchymal stem cells state
  publication-title: Sultan Qaboos Univ Med J
– volume: 9
  start-page: 205
  issue: 2
  year: 2019
  end-page: 218
  article-title: Understanding apoptosis and apoptotic pathways targeted cancer therapeutics
  publication-title: Adv Pharm Bull
– volume: 2
  start-page: 16022
  year: 2016
  article-title: Pancreatic cancer
  publication-title: Nat Rev Dis Primers
– volume: 45
  start-page: 115
  issue: 2
  year: 2008
  end-page: 120
  article-title: Adipose‐derived stem cells: isolation, expansion and differentiation
  publication-title: Methods
– volume: 144
  start-page: 1401
  issue: 6
  year: 2019
  end-page: 1413
  article-title: Adipose tissue‐derived stromal cells are sources of cancer‐associated fibroblasts and enhance tumor progression by dense collagen matrix
  publication-title: Int J Cancer
– volume: 4
  start-page: e6278
  issue: 7
  year: 2009
  article-title: Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo
  publication-title: PLoS One
– start-page: 255
  year: 2012
  end-page: 286
– volume: 13
  start-page: 1
  issue: 1
  year: 2023
  end-page: 14
  article-title: An enzyme‐free technique enables the isolation of a large number of adipose‐derived stem cells at the bedside
  publication-title: Sci Rep
– volume: 68
  issue: August 2020
  year: 2021
  article-title: Evaluating the in vitro therapeutic effects of human amniotic mesenchymal stromal cells on MiaPaca2 pancreatic cancer cells using 2D and 3D cell culture model
  publication-title: Tissue Cell
– volume: 18
  start-page: 142
  issue: 3
  year: 2016
  end-page: 151
  article-title: Mesenchymal stem cells promote pancreatic tumor growth by inducing alternative polarization of macrophages
  publication-title: Neoplasia
– volume: 117
  start-page: 279
  issue: 2
  year: 2016
  end-page: 288
  article-title: Control of apoptosis in treatment and biology of pancreatic cancer
  publication-title: J Cell Biochem
– ident: e_1_2_11_5_1
  doi: 10.3748/wjg.v17.i24.2897
– ident: e_1_2_11_30_1
  doi: 10.1002/IJC.31775
– ident: e_1_2_11_2_1
  doi: 10.1158/0008-5472.CAN-14-0155
– ident: e_1_2_11_10_1
  doi: 10.3389/FCELL.2020.00447
– ident: e_1_2_11_23_1
  doi: 10.1002/JCB.25284
– ident: e_1_2_11_16_1
  doi: 10.1016/j.ymeth.2008.03.006
– ident: e_1_2_11_13_1
  doi: 10.3390/ijms20153827
– ident: e_1_2_11_32_1
  doi: 10.1038/s41419-019-1959-5
– ident: e_1_2_11_19_1
  doi: 10.1371/JOURNAL.PONE.0010088
– ident: e_1_2_11_4_1
  doi: 10.1016/S0140-6736(20)30974-0
– ident: e_1_2_11_21_1
  doi: 10.1016/j.tice.2020.101479
– ident: e_1_2_11_14_1
  doi: 10.1371/journal.pone.0045590
– ident: e_1_2_11_7_1
  doi: 10.1186/s12943-018-0858-1
– ident: e_1_2_11_17_1
  doi: 10.1038/s41598-023-34915-0
– ident: e_1_2_11_18_1
  doi: 10.18295/squmj.2018.18.03.002
– ident: e_1_2_11_24_1
  doi: 10.15171/apb.2019.024
– ident: e_1_2_11_31_1
  doi: 10.1186/S13287-022-02910-3/FIGURES/7
– ident: e_1_2_11_34_1
  doi: 10.3389/fonc.2022.1047907
– ident: e_1_2_11_3_1
  doi: 10.1038/nrdp.2016.22
– ident: e_1_2_11_9_1
  doi: 10.1016/J.JSS.2007.12.757
– ident: e_1_2_11_20_1
  doi: 10.1016/J.CIS.2019.03.002
– ident: e_1_2_11_8_1
  doi: 10.1186/1756-8722-7-14
– ident: e_1_2_11_28_1
  doi: 10.1155/2015/361326
– ident: e_1_2_11_25_1
  doi: 10.1186/s40364-020-00228-x
– ident: e_1_2_11_29_1
  doi: 10.1371/journal.pone.0006278
– ident: e_1_2_11_26_1
  doi: 10.1016/j.bbcan.2013.10.004
– ident: e_1_2_11_22_1
  doi: 10.1016/J.SEMCANCER.2015.02.006
– ident: e_1_2_11_11_1
  doi: 10.1155/2017/4015039
– ident: e_1_2_11_33_1
  doi: 10.1016/J.NEO.2016.01.005
– ident: e_1_2_11_15_1
  doi: 10.2174/138920371604150429152720
– ident: e_1_2_11_6_1
  doi: 10.1016/j.semcancer.2017.03.008
– ident: e_1_2_11_27_1
  doi: 10.1371/journal.pone.0149876
– ident: e_1_2_11_12_1
  doi: 10.5772/31933
SSID ssj0000702671
Score 2.300397
Snippet Background One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the...
One of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the literature, the...
BackgroundOne of the main reasons for the unsuccessful treatment of pancreatic cancer is the intense desmoplastic pancreatic microenvironment. In the...
In our study, we showed that the tumorigenic effects of ADMSCs on Panc‐1 cells were altered when stimulated via TLR4 signaling, but this effect was altered...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e6964
SubjectTerms Adenocarcinoma
Adipose Tissue
Angiogenesis
Anti-Inflammatory Agents
Antitumor activity
Apoptosis
Body fat
Cancer therapies
Carcinoma, Pancreatic Ductal - genetics
Carcinoma, Pancreatic Ductal - metabolism
Carcinoma, Pancreatic Ductal - therapy
Cell cycle
Cell growth
Cell proliferation
Collagen (type I)
Cytokines
E-cadherin
Experiments
Gelatinase A
Gelatinase B
Genotype & phenotype
Humans
Inflammation
Insulin-like growth factor II receptors
Liposuction
Mesenchymal stem cells
Mesenchymal Stem Cells - metabolism
Metastases
Metastasis
MSC1
Mutation
Pancreatic cancer
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - therapy
Penicillin
Phenotypes
Stem cells
Tissue inhibitor of metalloproteinase 1
TLR4
TLR4 protein
Toll-Like Receptor 4 - genetics
Toll-Like Receptor 4 - metabolism
Toll-like receptors
Tumor Microenvironment
Tumors
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgSIgL4ptAQQZx4GKaxHYSn9CqoqoQywG10t4ix56oKxFn6e5W6pVfzkziDawK7CkrT-Q4Mx6_mdhvGHvXOAOI6p1QvlJCgQZRqQZjHq0ghVQql9Lh5PnX4vRcfV7oRUy4reO2yp1PHBy17x3lyI9yg9heIp7IP65-CKoaRV9XYwmN2-wOUZdR8FUuyinHguacF2W2IxRK8yNnO_WhMIXaX4ZuYMubWyT_hK7D2nPygN2PoJHPRi0_ZLcgPGJ35_Gz-GP2cxY2S7HZdvTAEJaOx20avG95sOjQuA2en335psSK-Pw9t3656tcgPFrgFf7v6BSSu7jusB_iduaU0cf7A0d3MSJLx4kbFtst-ipcAi-x876zo-QTdn7y6ez4VMTiCsIp_AnZmsrjZDdQoFKM1yp3rvRgESDYlk6oUjABuvJlXsi20VoWymE8a7VNwVfyKTsIfYDnjGe2kVTlqiwdHevVRmqrHShoLWQgTcLe79517SLzOBXA-F6PnMl5TWqpSS0JezuJrka6jb8JHe4UVscZt65_20fC3kzNOFfoJdgA_XaQMVriyIqEPRv1O_VCkbqRMktYtaf5SYB4uPdbwvJi4OPOqFqbySSOczCSfz95fTybK7p48f8hvGT3cgRPY6rnkB1sLrfwCsHPpnk9WPgvBYAGHQ
  priority: 102
  providerName: ProQuest
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9RAEB5qBfGl-NtolVV88CU2ye7msvh0FEsRT0Ra6FvY7E7ogdkcvbuCb33so3-jf4kzSS56VME8hewkm2Rmdr_ZZL4BeFM5g4TqXax8oWKFGuNCVRTzaIUJJlK5hJOTZ5_z41P18Uyf7cD7TS5Mzw8xLrixZ3TjNTu4rZYHv0lDnW3Uu9zk6hbc5tRaNvJMfRkXWMiWs7wLuJhxPSY_UhtmoSQ7GM_eno9ugMyb_0r-iWG7SejoHuwN6FFMe3Xfhx0MD-DObPg-_hCup2E1_3n1Y7VuuOIVhrkTwx8boq1FsDS2CRu8OPn0VZHcgsn9vbB-vmiXSAc8GeQlHWk4Kcmdf2-oN6Z6FrzAT9cIgkaPHmg6wVSx1G5p6KIZ8YJuoW1sL_kITo8-nBwex0Othdgp2mJZm8KT7xvMSUfGa5U5N_FoCS_YmhNWObZAXfhJlsu60lrmylF4a7VN0BfyMeyGNuBTEKmtJBe9mkwcZ_lqI7XVDhXWFlOUJoK3mzdeuoGInOthfCt7CuWsZOWUrJwIXo-ii559429C-xu1lYMDLsvMUCgoCX5mEbwam8l1-CXYgO26kzFa0pPlETzptTz2woG7kTKNoNjS_yjAtNzbLWF-3tFzp1y8zaSSnrMzlX_feXk4nSneefb_os_hbka4ql8F2ofd1cUaXxAuWlUvO_v_BW_NDUc
  priority: 102
  providerName: Wiley-Blackwell
Title Anti‐tumorigenic effects of naive and TLR4‐primed adipose‐derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcam4.6964
https://www.ncbi.nlm.nih.gov/pubmed/38379331
https://www.proquest.com/docview/2928736502
https://www.proquest.com/docview/2929539636
https://pubmed.ncbi.nlm.nih.gov/PMC10831913
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9swFD70AmMvY_d564I29rAXd7El2dbDGFlpV8ZSSmkgb0aWZBqo5SxNSvu6X75zfAkN7WB-MA46RraOjvQdxfo-gE-FUQ5RvQmFzUQonHRhJgrMeaRwQzfkwgxpc_L4JDmeiJ9TOd2CXmOza8CrB1M70pOaLC73b37ffsOA_9oRiH4xuhL7iUrENuzihJSSgsO4Q_nNgJySzBKlXsS9HmJEiZ5j6O7dmzPTPbh5_6vJu2i2mY6OnsKTDkeyUev4Z7Dl_HN4NO7-KX8Bf0Z-OQuXq4qUr5yfGdZ9ucHqknmNYxzT3rLzX2cinBPFv2Xazub1lQstdspr_F3RxiRzcVthPUT3zGiRH-_3DEeQFmwaRnSxWK5x-MJZcYGV15VuLV_C5Ojw_OA47PQWQiPwCHmpMovxr1yCflJWitiY1DqNmEGXtGmV8gsnM5vGCS8LKXkiDKa4Wuqhsxl_BTu-9u4NsEgXnISv0tTQTl-puNTSOOFK7SLHVQCf-7bOTUdGTpoYl3lLoxzn5Jac3BLAx7XpvGXgeMhor3dY3vehPFaYDnKEoHEAH9bFGD7UCNq7etXYKMnxzZIAXrf-XddCybviPAog2_D82oCouTdL_OyioeiOSMBNRRzfs-kk_37y_GA0FnTx9j-e8R08jhFUtUtAe7CzXKzcewRFy2IA27E4xXM6TQew-_3w5PRs0Cww4PnHNBo0IfEXwnwQ_w
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN8UBhgEEi9hSWyn8QNCZWzqWFuhqZP2ljm2o1Vakm5tQXvlD-Jv5K75gGrA2_KUyJc49p3vfv64O4A3qVEOUb3xhI2FJ5x0XixSnPNI4Xznc2F8ck4ejaPBkfhyLI834GfjC0PHKhuduFLUtjS0Rr4dKsT2HPFE-HF27lHWKNpdbVJoVGJx4C6_45Rt_mH_M_L3bRju7U52Bl6dVcAzAi-PZyq2KOXKRfg3ykoRGtOzTqNl1Bm5ZhKKdjK2vTDiWSolj4TBiZyW2nc25vjdG7ApOEKFDmx-2h1_PWxXdXAAhVEvaEIY-eG20bl4H6lIrBu-K2j26qHMP8Hyytrt3YU7NUxl_Uqu7sGGK-7DzVG9Ef8AfvSLxdRbLHPqIldMDasPhrAyY4VGFcp0YdlkeCi8GWUQsEzb6aycO8-izH_D55z8nszpZY71UDRpRnsI-H7BUEFVWNYwikaL5Rq1IxrdC6y8zHVF-RCOrqXjH0GnKAv3BFigU055tXo9Q47EUnGppXHCZdoFjqsuvGv6OjF1rHNKuXGWVFGaw4TYkhBbuvC6JZ1VAT7-RrTVMCypx_g8-S2RXXjVFuPopE7QhSuXKxolObYs6sLjir9tLbQ2oDgPuhCvcb4loMjf6yXF9HQVATyg_HAq4NjOlZD8-8-Tnf5I0M3T_zfhJdwaTEbDZLg_PngGt0OEbtVC0xZ0FhdL9xyh1yJ9Ucs7g5PrHmK_ANIDQxY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcEG8MBRYEEhfT2Ltrew8IRS1RS5sKoVbKzax3x2okvA5NAuqVn8WvY8aPQFTg1pwc7dj7mNe3rxnGXhZWA6J6G0qXyVCCgjCTBc55lIQBDIS0A7qcPD5O9k_lh4mabLCf_V0YOlbZ28TGULva0hr5TqwR2wvEE_FO2R2L-Lg3ejf7GlIGKdpp7dNptCJyCBffcfo2f3uwh7x-Fcej9ye7-2GXYSC0En-hKHXmUOI1JNgy7ZSMrU0dGPSSpqRrmoSoQWUujRNRFkqJRFqc1BllBuAygd-9xq6nAt0m6lI6SVfrO6hKcZJGfTAjbLY1lXyT6ESuu8BLuPby8cw_YXPj90a32M0OsPJhK2G32Qb4O2xr3G3J32U_hn4xDRfLigYI_NTy7ogIr0vuDRpTbrzjJ0efZDijXAKOGzed1XMIHUr_N_xf0Q0oe3ZRYT0UV5rTbgK-7zmaqhbVWk5xabHcoJ1E93uOldeVaSnvsdMrGfb7bNPXHh4yHplCUIatNLV0pVhpoYyyIKE0EIHQAXvdj3Vuu6jnlHzjS97Ga45zYktObAnYixXprA318Tei7Z5heaft8_y3bAbs-aoY9ZQGwXiolw2NVgJ7lgTsQcvfVS20SqCFiAKWrXF-RUAxwNdL_PSsiQUeUaY4HQnsZyMk_255vjscS3p49P8uPGNbqFj50cHx4WN2I0YM1644bbPNxfkSniAGWxRPG2Hn7PNVa9cvM2RF5g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-tumorigenic+effects+of+naive+and+TLR4-primed+adipose-derived+mesenchymal+stem+cells+on+pancreatic+ductal+adenocarcinoma+cells&rft.jtitle=Cancer+medicine+%28Malden%2C+MA%29&rft.au=Ka%C3%A7aro%C4%9Flu%2C+Demet&rft.au=Yaylac%C4%B1%2C+Seher&rft.au=Gurbuz%2C+Nilgun&rft.date=2024-01-01&rft.issn=2045-7634&rft.eissn=2045-7634&rft.volume=13&rft.issue=2&rft.spage=e6964&rft_id=info:doi/10.1002%2Fcam4.6964&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-7634&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-7634&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-7634&client=summon